-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L3ZFvwbNSw7+oDYUZMsrx09JFblCx4uwZu0G92pIQRTPVQ2IymKzcagvSAaXLr7M a41ysWxctYfZOkujBDtIxw== 0000950123-07-016498.txt : 20071210 0000950123-07-016498.hdr.sgml : 20071210 20071210170821 ACCESSION NUMBER: 0000950123-07-016498 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071204 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20071210 DATE AS OF CHANGE: 20071210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biodel Inc CENTRAL INDEX KEY: 0001322505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 071296417 BUSINESS ADDRESS: STREET 1: 100 SAW MILL ROAD CITY: DANBURY STATE: CT ZIP: 06810 BUSINESS PHONE: 203-796-5000 MAIL ADDRESS: STREET 1: 100 SAW MILL ROAD CITY: DANBURY STATE: CT ZIP: 06810 8-K 1 y44367e8vk.htm FORM 8-K FORM 8-K
 

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 4, 2007
BIODEL INC.
 
(Exact Name of Registrant as Specified in Charter)
         
Delaware   001-33451   90-0136863
 
(State or Other Juris-
diction of Incorporation 		  (Commission
File Number) 		  (IRS Employer
Identification No.)
     
100 Saw Mill Road
Danbury, Connecticut 		 
06810
 
(Address of Principal Executive Offices)   (Zip Code)
Registrant’s telephone number, including area code (203) 796-5000
6 Christopher Columbus Avenue, Danbury Connecticut 06810
 
(Former Name or Former Address, if Changed Since Last Report)
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e) 2007 Cash Bonus Awards and 2008 Base Salary for Named Executive Officers.
     On December 4, 2007, the Board of Directors of Biodel Inc. (the “Company”) approved (i) base salary increases for the 2008 fiscal year for each of the Company’s “named executive officers” (as used in Instruction 4 to Item 5.02 of Form 8-K), (ii) payment of annual incentive cash bonus awards for performance during the 2007 fiscal year (“2007 Cash Bonus Awards”) to certain named executive officers and (iii) awards of options to purchase shares of the Company’s common stock to certain named executive officers (the “Option Awards”). The following table sets forth information regarding each of the named executive officer’s (i) 2007 base salary (for comparison purposes only), (ii) 2007 Cash Bonus Award, (ii) 2008 base salary and (iv) Option Award:
                                     
Executive       2007 Base     2007 Cash              
Officer             Title   Salary (1)     Bonus     2008 Base Salary (2)     Option Award(3)  
 
Solomon S. Steiner
   President & Chief   $ 250,000     $ 200,000 (4)   $ 375,000       200,000  
 
   Executive Officer                                
 
                                    
Erik Steiner
   Vice President,   $ 150,000     $ 50,000 (5)   $ 200,000       60,000  
 
   Operations                                
 
                                    
Roderike Pohl
   Vice President,   $ 150,000     $ 0     $ 200,000       50,000  
 
   Research                                
  (1)   Base salary as of September 30, 2007.
 
  (2)   Base salary increases were effective as of December 1, 2007, with the exception of Dr. Solomon S. Steiner, who received his increase effective November 20, 2007 pursuant to his an amended and restated employment agreement with the Company.
 
  (3)   Options were granted pursuant to the Company’s Amended and Restated 2004 Stock Incentive Plan and each Option Award will vest in four equal annual installments.
 
  (4)   The Company granted Dr. Solomon S. Steiner’s 2007 Cash Bonus Award pursuant to his amended and restated employment agreement with the Company. The 2007 Cash Bonus Award was based on Dr. Steiner’s individual performance in fiscal year 2007.
 
  (5)   The Company granted Mr. Erik Steiner’s 2007 Cash Bonus Award based his individual performance in fiscal year 2007.

 

 

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  BIODEL INC.
 		  
Date: December 10, 2007  By:   /s/  Solomon S. Steiner  
    Solomon S. Steiner   
    Chief Executive Officer   
 

 

-----END PRIVACY-ENHANCED MESSAGE-----